Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology.

Pharmaceutical

Eyenovia

Eyenovia's headquarters in New York, NY, United States

Sean Ianchulev

Daryn Caldwell

Lauren Grizzard

Enrico Brambilla

Greg Bennett

John Gandolfo

Robert N. Weinreb

Pamela Gallin

Charles Mather

Mark Bullimore

Rachel Jacobson

Stephen Benjamin

Ram Palanki

Ellen Strahlman

James C. Tsai

Jason Jones

Francis Mah

The Scientific Advisors team at Eyenovia plays a crucial role in guiding the company's research and development efforts by providing expertise in ophthalmic science and therapeutics. They collaborate with internal teams to refine product strategies, ensure alignment with clinical standards, and help navigate regulatory landscapes. Their insights are vital in advancing the company's innovative microdose array print platform and optimizing its clinical trials for maximum efficacy and safety.

Scientific Advisors

The Clinical Operations team at Eyenovia is responsible for overseeing the planning, implementation, and monitoring of clinical trials related to the company's advanced ophthalmic therapeutics. This team ensures compliance with regulatory standards and manages safety protocols while collaborating with various stakeholders to achieve efficient and timely trial execution. Their work is vital in guiding the development of innovative treatments using Eyenovia’s proprietary technology.

Clinical Operations

The Leadership Team at Eyenovia oversees the strategic direction and operational management of the company, guiding the development of innovative ophthalmic therapeutics. Composed of the CEO, CFO, and COO, among others, this team collaborates to ensure the successful execution of the company's clinical programs, financial stability, and alignment with its mission to advance eye care through cutting-edge technology.

Leadership Team

The Quality Assurance and Regulatory Affairs team at Eyenovia is responsible for ensuring that all products meet stringent quality standards and regulatory requirements throughout the development process. This team oversees compliance with industry regulations, implements quality management systems, and facilitates communication with regulatory agencies to support the successful introduction of innovative ophthalmic therapies. Their expertise ensures that Eyenovia's therapeutics are safe, effective, and ready for market launch.

Quality Assurance and Regulatory Affairs

The Finance and Administration team at Eyenovia is responsible for managing the company’s financial health and ensuring compliance with accounting standards. This team oversees budgeting, forecasting, and financial reporting, while also managing costs to support the development of innovative ophthalmic therapeutics. By providing critical financial insights and strategic support, they help drive the company's growth and operational efficiency.

Finance and Administration

The Research and Development team at Eyenovia focuses on advancing the company’s pipeline of innovative ophthalmic therapeutics. This team is responsible for overseeing product research, ensuring compliance with regulatory standards, managing data integrity, and utilizing cutting-edge technologies to refine and enhance drug delivery methods through the proprietary microdose array print platform. Their collaborative efforts drive the development of effective treatments aimed at improving patient outcomes in eye care.

Eyenovia

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Operations

Leadership Team

Quality Assurance and Regulatory Affairs

Finance and Administration

Research and Development

Offices

Eyenovia

Org chart

Board & advisors

Teams

Scientific Advisors

Clinical Operations

Leadership Team

Quality Assurance and Regulatory Affairs

Finance and Administration

Research and Development

Offices

Related companies